+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

In Vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan



In Vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan



Antimicrobial Agents and ChemoTherapy 51(5): 1849-1851



The in vitro activities of isepamicin against 117 Mycobacteria abscessus, 48 Mycobacterium fortuitum, and 20 Mycobacterium chelonae isolates were evaluated by a microdilution test. Isepamicin MIC(90)s were < or =16 microg/ml for the three species. Isepamicin was as active as amikacin and kanamycin and more active than tobramycin, capreomycin, gentamicin, and streptomycin.

(PDF emailed within 0-6 h: $19.90)

Accession: 013734947

Download citation: RISBibTeXText

PMID: 17353252

DOI: 10.1128/AAC.01551-06


Related references

In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections. Journal of Microbiology, Immunology, and Infection 40(6): 481-486, 2007

Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan. International Journal of Antimicrobial Agents 41(3): 218-223, 2013

In vitro interaction of some drug combinations to inhibit rapidly growing mycobacteria isolates from cats and dogs and these isolates' susceptibility to cefovecin and clofazimine. Australian Veterinary Journal 93(1-2): 40-45, 2015

In vitro activity of linezolid against isolates of rapidly growing mycobacteria. Abstracts of the General Meeting of the American Society for Microbiology 100: 654, 2000

In vitro activity of a novel des-fluoro quinolone, garenoxacin , against rapidly growing mycobacteria and Nocardia isolates. Journal of Antimicrobial Chemotherapy 50(1): 140-142, July, 2002

In vitro activity of a novel des-fluoro quinolone BMS-284756 against rapidly growing mycobacteria and Nocardia isolates. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 175, 2001

The resistance of clinical isolates of gram-negative bacilli against isepamicin and other aminoglycosides. Infeksiyon Dergisi = Turkish Journal of Infection 17(1): 49-53, 2003

In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria. Antimicrobial Agents and ChemoTherapy 52(11): 4184-4186, 2008

Prevalence of erm methylase genes in clinical isolates of non-pigmented, rapidly growing mycobacteria. Clinical Microbiology and Infection 15(10): 919-923, 2009

Mercuric reductase hgre activity in clinical isolates of rapidly growing mycobacteria rgm. Abstracts of the Annual Meeting of the American Society for Microbiology 88: 135, 1988

In vitro activity of a novel des-fluoro(6) quinolone, garenoxacin (BMS-284756), against rapidly growing mycobacteria and Nocardia isolates. Journal of Antimicrobial ChemoTherapy 50(1): 140-142, 2002

In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria. Antimicrobial Agents and ChemoTherapy 50(12): 4027-4029, 2006

Comparison of in vitro activities of gatifloxacin and ciprofloxacin against four taxa of rapidly growing mycobacteria. Antimicrobial Agents and ChemoTherapy 46(10): 3283-3285, 2002

Detection of lfrA and tap efflux pump genes among clinical isolates of non-pigmented rapidly growing mycobacteria. International Journal of Antimicrobial Agents 34(5): 454-456, 2009

In Vitro Comparison of Ertapenem, Meropenem, and Imipenem against Isolates of Rapidly Growing Mycobacteria and Nocardia by Use of Broth Microdilution and Etest. Journal of Clinical Microbiology 54(6): 1586-1592, 2017